TY - JOUR
T1 - Bacterial meningitis in patients with multiple myeloma
T2 - a prospective nationwide cohort study and review of the literature
AU - Sheybani, Fereshte
AU - Brouwer, Matthijs C.
AU - van de Beek, Diederik
N1 - Funding Information: This study is supported by the Netherlands Organization for Health Research and Development (ZonMw; NWO-Vici-Grant [91819627] to DvdB, NWO-Vidi-Grant [916.13.078] to MCB), and the European Research Council (European Research Council Starting Grant to Dvd.; European Research Council Consolidator Grant to MCB). Publisher Copyright: © 2022 The Author(s)
PY - 2022/9
Y1 - 2022/9
N2 - Objectives: To study the clinical features of bacterial meningitis in patients with myeloma. Methods: We analyzed patients with myeloma who were included in a nationwide cohort of patients >16 years old with community-acquired bacterial meningitis in the Netherlands from 2006 to 2018. Subsequently, we reviewed the literature for articles reporting patients with myeloma with bacterial meningitis. Results: A total of 27 of 2306 episodes (1.6%) of bacterial meningitis occurred in patients with myeloma. Six of 27 patients (22%) underwent stem cell transplantation. Median cerebrospinal fluid (CSF) leukocyte count was 172/µl, and 12 of 26 patients (46%) had a CSF leukocyte count <100/µl. Streptococcus pneumoniae was the causative pathogen in 25 patients (93%). Fourteen patients (52%) had unfavorable outcomes, of whom 10 (37%) died. Ninety-one patients with myeloma with bacterial meningitis were described in the literature. The most common pathogen in these patients was S. pneumoniae (35 of 48; 73%) and four (20%) of 20 patients died. Conclusion: Bacterial meningitis in patients with multiple myeloma is a severe disease with high rates of unfavorable outcome. Patients often present with a lower CSF leukocyte count than patients with bacterial meningitis without multiple myeloma. Physicians should set a low threshold to perform lumbar puncture in patients with myeloma and start antibiotic treatment pending CSF chemistry and culture results.
AB - Objectives: To study the clinical features of bacterial meningitis in patients with myeloma. Methods: We analyzed patients with myeloma who were included in a nationwide cohort of patients >16 years old with community-acquired bacterial meningitis in the Netherlands from 2006 to 2018. Subsequently, we reviewed the literature for articles reporting patients with myeloma with bacterial meningitis. Results: A total of 27 of 2306 episodes (1.6%) of bacterial meningitis occurred in patients with myeloma. Six of 27 patients (22%) underwent stem cell transplantation. Median cerebrospinal fluid (CSF) leukocyte count was 172/µl, and 12 of 26 patients (46%) had a CSF leukocyte count <100/µl. Streptococcus pneumoniae was the causative pathogen in 25 patients (93%). Fourteen patients (52%) had unfavorable outcomes, of whom 10 (37%) died. Ninety-one patients with myeloma with bacterial meningitis were described in the literature. The most common pathogen in these patients was S. pneumoniae (35 of 48; 73%) and four (20%) of 20 patients died. Conclusion: Bacterial meningitis in patients with multiple myeloma is a severe disease with high rates of unfavorable outcome. Patients often present with a lower CSF leukocyte count than patients with bacterial meningitis without multiple myeloma. Physicians should set a low threshold to perform lumbar puncture in patients with myeloma and start antibiotic treatment pending CSF chemistry and culture results.
KW - Bacterial meningitis
KW - Multiple myeloma
KW - Streptococcus pneumoniae
UR - http://www.scopus.com/inward/record.url?scp=85133913208&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.ijid.2022.06.038
DO - https://doi.org/10.1016/j.ijid.2022.06.038
M3 - Article
C2 - 35760383
SN - 1201-9712
VL - 122
SP - 492
EP - 496
JO - International journal of infectious diseases : IJID
JF - International journal of infectious diseases : IJID
ER -